Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Anaferon:

[Immunotropic properties of anaferon and anaferon pediatric]. Zhavbert ES et al. Antibiot Khimioter. (2013)

[Study of efficacy of anaferon pediatric in mice infected by pandemic influenza virus A(H1N1/09)v]. Shishkina LI et al. Zh Mikrobiol Epidemiol Immunobiol. (2011)

Efficiency of anaferon in complex therapy of genital herpes. Zuikova IN et al. Bull Exp Biol Med. (2009)

Search results

Items: 1 to 20 of 23

1.

Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results.

Petrova NV, Emelyanova AG, Gorbunov EA, Edwards MR, Walton RP, Bartlett NW, Aniscenko J, Gogsadze L, Bakhsoliani E, Khaitov MR, Johnston SL, Tarasov SA, Epstein OI.

Antiviral Res. 2017 Jun;142:185-192. doi: 10.1016/j.antiviral.2017.03.017. Epub 2017 Mar 27.

2.

Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.

Don ЕS, Emelyanova AG, Yakovleva NN, Petrova NV, Nikiforova MV, Gorbunov EA, Tarasov SА, Morozov SG, Epstein ОI.

J Med Virol. 2017 May;89(5):759-766. doi: 10.1002/jmv.24717. Epub 2016 Nov 9.

PMID:
27769099
3.

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia.

Vetlugina TP, Lobacheva OA, Sergeeva SA, Nikitina VB, Nevidimova TI, Semke AV.

Acta Neuropsychiatr. 2016 Jun;28(3):149-56. doi: 10.1017/neu.2015.60. Epub 2015 Nov 16.

PMID:
26567593
4.

[The treatment of influenza and acute respiratory viral infections].

Kramarev SA, Moshchich AP.

Lik Sprava. 2013 Mar;(2):99-106. Review. Russian.

PMID:
24605619
5.

[Immunotropic properties of anaferon and anaferon pediatric].

Zhavbert ES, Dugina IuL, Épshteĭn OI.

Antibiot Khimioter. 2013;58(5-6):17-23. Russian.

PMID:
24757821
6.

Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice.

Tarasov SA, Zarubaev VV, Gorbunov EA, Sergeeva SA, Epstein OI.

Antiviral Res. 2012 Feb;93(2):219-24. doi: 10.1016/j.antiviral.2011.11.018. Epub 2011 Dec 8.

PMID:
22178245
7.

[Study of efficacy of anaferon pediatric in mice infected by pandemic influenza virus A(H1N1/09)v].

Shishkina LI, Skarnovich MO, Kabanov AS, Sergeev AA, Tarasov SA, Sergeeva SA, Épshteĭn, Malkova EM, Stavskiĭ EA, Drozdov IG.

Zh Mikrobiol Epidemiol Immunobiol. 2011 Jan-Feb;(1):83-6. Russian.

PMID:
21446173
8.

Antiviral activity of Anaferon (pediatric formulation) in mice infected with pandemic influenza virus A(H1N1/09).

Shishkina LN, Skarnovich MO, Kabanov AS, Sergeev AA, Olkin SE, Tarasov SA, Belopolskaya MV, Sergeeva SA, Epstein OI, Malkova EM, Stavsky EA, Drozdov IG.

Bull Exp Biol Med. 2010 Oct;149(5):612-4.

PMID:
21165400
9.

Preclinical studied of general toxic properties of preparations containing ultralow doses of antibodies to endogenous regulators.

Karpova GV, Fomina TI, Vetoshkina TV, Dubskaya TY, Voronova OL, Timina EA, Abramova EV, Ermolaeva LA, Perova AV.

Bull Exp Biol Med. 2009 Sep;148(3):543-6. English, Russian.

PMID:
20396736
10.

Complex application of preparation containing ultralow doses of antibodies for the treatment of anemia caused by pubertal uterine bleedings.

Sotnikova LS, Shevtsova NM, Sherstoboev EY, Zhdanov VV, Dygai AM.

Bull Exp Biol Med. 2009 Sep;148(3):505-7. English, Russian.

PMID:
20396724
11.

Effect of combination of anticytokine preparations anaferon and artrofoon on immune inflammation in rheumatoid arthritis.

Petrov VI, Babaeva AR, Solodenkova KS, Cherevkova EV, Zabolotneva YA, Kachanova MV, Sergeeva SA.

Bull Exp Biol Med. 2009 Sep;148(3):489-92. English, Russian.

PMID:
20396720
12.
13.

Efficiency of anaferon in complex therapy of genital herpes.

Zuikova IN, Vasil'ev AN, Shul'zhenko AE.

Bull Exp Biol Med. 2009 Aug;148(2):297-300.

PMID:
20027352
14.

Application of ultralow doses of antibodies to interferon-gamma in complex therapy of bacterial infections and prophylaxis of bacterial complications.

Tarasov SA, Kachanova MV, Zhavbert ES, Dugina YL, Epshtein OI, Sergeeva SA.

Bull Exp Biol Med. 2009 Aug;148(2):295-6.

PMID:
20027351
15.

Evaluation of the efficiency and safety of anaferon (pediatric formulation) in the treatment of chickenpox in children.

Timchenko VN, Pavlova EB, Chernova TM, Bannova SL, Savel'eva TI, Tarasov SA, Kachanova MV, Siver'yanova MA.

Bull Exp Biol Med. 2009 Aug;148(2):291-4.

PMID:
20027350
16.

Clinical and immunological efficiency of anaferon (pediatric formulation) in calicivirus infection in children.

Tikhomirova OV, Razd'yakonova IV, Bekhtereva MK, Zheleznikova GF, Monakhova NE, Sirotkin AK.

Bull Exp Biol Med. 2009 Aug;148(2):287-90.

PMID:
20027349
17.

Acute viral infections with combined involvement of the respiratory and gastrointestinal tracts in children. Therapy with interferon.

Dondurei EA, Osidak LV, Golovacheva EG, Golovanova AK, Amosova IV, Gladchenko LN.

Bull Exp Biol Med. 2009 Aug;148(2):283-6.

PMID:
20027348
18.

Anaferon (pediatric formulation) in prophylactics of acute respiratory viral infection in children.

Kudin MV, Tarasov SA, Kachanova MV, Skripkin AV, Fedorov YN.

Bull Exp Biol Med. 2009 Aug;148(2):279-82.

PMID:
20027347
19.

Interferon status in children during acute respiratory infections. Therapy with interferon.

Obraztsova EV, Osidak LV, Golovacheva EG, Afanas'eva OI, Mil'kint KK, Koroleva EG, Drinevskii VP, Vasil'eva IA.

Bull Exp Biol Med. 2009 Aug;148(2):275-8.

PMID:
20027346
20.

Efficiency of interferon inductor anaferon (pediatric formulation) in prophylaxis of acute respiratory infections in sickly children.

Erman ES, Osidak LV, Sukhovetskaya VF, Drinevskii VP.

Bull Exp Biol Med. 2009 Aug;148(2):270-4.

PMID:
20027345

Supplemental Content

Loading ...
Support Center